|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Rheumatology Unit (RGM, MJJ, and LGC), the Cardiothoracic Surgery Unit (JRME, JS, and RS), and the Cardiovascular Research Centre (GDY and KR-T), Royal Adelaide Hospital, Adelaide, Australia; the School of Agriculture Food and Wine (RAG) and the School of Medicine (MJJ, LGC, and GDY), University of Adelaide, Adelaide, Australia; and the Hanson Institute, Adelaide, Australia (MJJ and LGC)
Background: Increased fish or fish-oil consumption is associated with reduced risk of cardiac mortality, especially sudden death. This benefit putatively arises from the incorporation of the long-chain n3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) into cardiomyocyte phospholipids.
Objective: The study examined the kinetics of incorporation of n3 fatty acids into human myocardial membrane phospholipids during supplementation with fish oil and
-linolenic acidrich flaxseed oil.
Design: Patients with low self-reported fish intake (<1 fish meal/wk and no oil supplements) accepted for elective cardiac surgery involving cardiopulmonary bypass were randomly allocated to 1 of 6 groups: no supplement; fish oil (6 g EPA+DHA/d) for either 7, 14, or 21 d before surgery; flaxseed oil; or olive oil (both 10 mL/d for 21 d before surgery). Right atrial appendage tissue removed during surgery and blood collected at enrollment and before surgery were analyzed for phospholipid fatty acids.
Results: Surgery rescheduling resulted in a range of treatment times from 7 to 118 d. In the fish-oil-treated subjects, accumulation of EPA and DHA in the right atrium was curvilinear with time and reached a maximum at
30 d of treatment and displaced mainly arachidonic acid. Flaxseed oil supplementation yielded a small increase in atrial EPA but not DHA, whereas olive oil did not significantly change atrial n3 fatty acids.
Conclusion: The results of the present study show that dietary n3 fatty acids are rapidly incorporated into human myocardial phospholipids at the expense of arachidonic acid during high-dose fish-oil supplementation.
Key Words: Fish oils fatty acids n3 fatty acids dietary fats myocardium humans
This article has been cited by other articles:
![]() |
J. W. Fetterman Jr. and M. M. Zdanowicz Therapeutic potential of n-3 polyunsaturated fatty acids in disease Am. J. Health Syst. Pharm., July 1, 2009; 66(13): 1169 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Aarsetoey, V. Ponitz, H. Grundt, H. Staines, W. S. Harris, and D. W. T. Nilsen (n-3) Fatty Acid Content of Red Blood Cells Does Not Predict Risk of Future Cardiovascular Events following an Acute Coronary Syndrome J. Nutr., March 1, 2009; 139(3): 507 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Duda, K. M. O'Shea, A. Tintinu, W. Xu, R. J. Khairallah, B. R. Barrows, D. J. Chess, A. M. Azimzadeh, W. S. Harris, V. G. Sharov, et al. Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction Cardiovasc Res, February 1, 2009; 81(2): 319 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lee, J. H. O'Keefe, C. J. Lavie, R. Marchioli, and W. S. Harris Omega-3 Fatty Acids for Cardioprotection Mayo Clin. Proc., March 1, 2008; 83(3): 324 - 332. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |